We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Implant Stiffness Leads to Foreign Body Reactions

By HospiMedica International staff writers
Posted on 25 Feb 2014
A new study reveals that surgical implant stiffness is a major cause of foreign body reaction (FBR) inflammatory reactions.

Researchers at the University of Cambridge (United Kingdom) implanted composite foreign bodies—one side as soft as neural tissue and the other as stiff as muscle—into rats' brains to examine the impact of an implant's stiffness on the inflammatory process. More...
The researchers found that both primary rat microglial cells and astrocytes responded to the increased contact stiffness by changes in morphology and upregulation of a multitude of inflammatory genes and proteins, with FBR significantly enhanced around the stiff portions of the implant.

The researchers found that the morphologically, the cells around the stiffer substrate were very flat, whereas those grown on the softer substrate looked much more like normal cells found in the brain. According to the researchers, the results suggest that adapting the surface stiffness of electrodes used as neural implants for the stimulation of nervous tissue could minimize adverse reactions and improve biocompatibility. The study was published early online on February 11, 2014, in Biomaterials.

“Brain tissue is as soft as cream cheese; it is one of the softest tissues in the body, and electrodes are orders of magnitude stiffer. The findings could have major implications for the design of implants used in the brain and other parts of the body,” said study coauthor Kristian Franze. “Our results suggest that in the short term, simply coating existing implants with materials that match the stiffness of the tissue they are being implanted into will help reduce foreign body reactions.”

Implant FBR in the brain can cause the implants to be encapsulated by reactive tissue, which in the CNS consists mainly of microglial cells and astrocytes, which are surrounded by extracellular matrix (ECM). The reactive process, which starts with the activation of glial cells, can damage local neurons, and the subsequent dendritic retraction and neuronal death may contribute to a gradual decline in the function of implanted electrodes.

Related Links:

University of Cambridge 



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.